Advantages and Critical Reappraisal of New Clinical Obesity Definition Proposed by Lancet Commission
Journal of Obesity & Metabolic Syndrome · 30.10.2026 · 35 (4) · 397-412
DOI: 10.7570/jomes26008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Obesity & Metabolic Syndrome, online erschienen am 08.10.2026. Verfasst von Soo Lim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Obesity. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
- Pennington Biomedical Research Center, Baton Rouge, LA, USA.
ORCID-Profile: Soo Lim, Donna H Ryan
Zitieren
APA
Lim, S., Choe, H. J., & Ryan, D. H. (2026). Advantages and Critical Reappraisal of New Clinical Obesity Definition Proposed by Lancet Commission. Journal of Obesity & Metabolic Syndrome, 35(4), 397-412. https://doi.org/10.7570/jomes26008
Vancouver
Lim S, Choe HJ, Ryan DH. Advantages and Critical Reappraisal of New Clinical Obesity Definition Proposed by Lancet Commission. Journal of Obesity & Metabolic Syndrome. 2026;35(4):397-412. doi:10.7570/jomes26008
BibTeX
@article{Lim2026,
author = {Lim, Soo and Choe, Hun Jee and Ryan, Donna H},
title = {Advantages and Critical Reappraisal of New Clinical Obesity Definition Proposed by Lancet Commission},
journal = {Journal of Obesity & Metabolic Syndrome},
year = {2026},
volume = {35},
number = {4},
pages = {397--412},
doi = {10.7570/jomes26008}
}
EUVIMED